NOS3 and cardiovascular disorder: This included NOS3 mRNA quantification, genotyping of an intronic putative non-coding RNA (ncRNA) locus suspicious for pathomechanistic relevance in cardiovascular diseases [22], monitoring of CpG signalling at the NOS3 promoter and quantification of PTMs relevant for chromatin structure regulation.